BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25252101)

  • 1. Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study.
    Hoffmann C; Hentrich M; Gillor D; Behrens G; Jensen B; Stoehr A; Esser S; van Lunzen J; Krznaric I; Müller M; Oette M; Hensel M; Thoden J; Fätkenheuer G; Wyen C
    HIV Med; 2015 Apr; 16(4):261-4. PubMed ID: 25252101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy.
    Gotti D; Danesi M; Calabresi A; Ferraresi A; Albini L; Donato F; Castelli F; Scalzini A; Quiros-Roldan E;
    AIDS Patient Care STDS; 2013 May; 27(5):259-65. PubMed ID: 23600703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma.
    Hoffmann C; Schommers P; Wolf E; Müller M; Schultze A; Krznaric I; Stoehr A; Wolf T; Fäktenheuer G; Stier B; Wyen C; Hentrich M
    AIDS; 2016 Mar; 30(5):753-60. PubMed ID: 26605513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
    Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A
    J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of immunovirological features in HIV related non-Hodgkin lymphoma patients and their impact on outcome.
    Tedeschi R; Bortolin MT; Bidoli E; Zanussi S; Pratesi C; Vaccher E; Tirelli U; De Paoli P
    J Clin Virol; 2012 Apr; 53(4):297-301. PubMed ID: 22244256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of non-Hodgkin lymphoma arising in HIV-infected patients with suppressed HIV replication.
    Gérard L; Meignin V; Galicier L; Fieschi C; Leturque N; Piketty C; Fonquernie L; Agbalika F; Oksenhendler E
    AIDS; 2009 Nov; 23(17):2301-8. PubMed ID: 19752717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
    Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
    J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
    Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short communication: spectrum of non-Hodgkin lymphoma in an urban Ryan White-funded clinic in the established antiretroviral era.
    Silverton A; Gunthel C; Adamski M; Mosunjac M; Nguyen ML
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):665-9. PubMed ID: 24707838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.
    Grulich AE; Wan X; Law MG; Milliken ST; Lewis CR; Garsia RJ; Gold J; Finlayson RJ; Cooper DA; Kaldor JM
    AIDS; 2000 Jan; 14(2):133-40. PubMed ID: 10708283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.
    Achenbach CJ; Buchanan AL; Cole SR; Hou L; Mugavero MJ; Crane HM; Moore RD; Haubrich RH; Gopal S; Eron JJ; Hunt PW; Rodriguez B; Mayer K; Saag MS; Kitahata MM;
    Clin Infect Dis; 2014 Jun; 58(11):1599-606. PubMed ID: 24523217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study.
    Hernández-Ramírez RU; Qin L; Lin H; Leyden W; Neugebauer RS; Althoff KN; Achenbach CJ; Hessol NA; D'Souza G; Gebo KA; Gill MJ; Grover S; Horberg MA; Li J; Mathews WC; Mayor AM; Park LS; Rabkin CS; Salters K; Justice AC; Moore RD; Engels EA; Silverberg MJ; Dubrow R;
    Lancet HIV; 2019 Apr; 6(4):e240-e249. PubMed ID: 30826282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort study.
    Spagnuolo V; Travi G; Galli L; Cossarini F; Guffanti M; Gianotti N; Salpietro S; Lazzarin A; Castagna A
    Cancer; 2013 Aug; 119(15):2710-9. PubMed ID: 23625649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
    Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
    Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, Treatment, and Outcome of HIV-Associated Hematologic Malignancies in People Living with HIV in Sweden.
    Kieri O; Marrone G; Sönnerborg A; Nowak P
    AIDS Res Hum Retroviruses; 2022 Feb; 38(2):135-142. PubMed ID: 34652958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.
    Yanik EL; Achenbach CJ; Gopal S; Coghill AE; Cole SR; Eron JJ; Moore RD; Mathews WC; Drozd DR; Hamdan A; Ballestas ME; Engels EA
    J Clin Oncol; 2016 Sep; 34(27):3276-83. PubMed ID: 27507879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: results from FHDH ANRS CO4.
    Fontas E; Kousignian I; Pradier C; Duvivier C; Poizot-Martin I; Durier C; Jarrousse B; Weiss L; Levy Y; Costagliola D;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):206-14. PubMed ID: 19131886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of HIV-associated Hodgkin's lymphoma in HIV-infected patients: a single-center experience.
    Ruiz M; Parsons C; Cole J
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(4):234-8. PubMed ID: 22302202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of microbial translocation and risk of AIDS-related lymphoma.
    Marks MA; Rabkin CS; Engels EA; Busch E; Kopp W; Rager H; Goedert JJ; Chaturvedi AK
    AIDS; 2013 Jan; 27(3):469-74. PubMed ID: 23169327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.